Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
How Tinted Lenses Affect Us?
People are fascinated by colors – whether in art, nature, fashion or, of course, the sciences. While there’s no doubt that colors can elicit certain emotions and associations, where exactly is the line between our gut feeling and actual science?…
J&J announced new products at the AAO annual meeting
Johnson & Johnson Vision announced a series of new products and innovations at the 2019 American Academy of Ophthalmology (AAO) Annual Meeting in San Francisco, CA, USA. The company announced the US Food & Drug Administration (FDA) approval of the…
VSY Biotech Signs Agreement With WAKAMOTO Pharma
Leinfelden – Echterdingen, Germany March 19, 2021, VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in ophthalmology, visco supplementation in orthopedy and medical esthetics, announced today an agreement with WAKAMOTO PHARMACEUTICAL CO., LTD. (hereinafter refer to…
Updates On Central Serous Chorioretinopathy
Central serous chorioretinopathy, commonly referred to as CSC, is a condition in which fluid accumulates under the retina, causing a serous (fluid-filled) detachment and vision loss. CSC most often occurs in young and middle-aged adults. For unknown reasons, men develop…
Alcon Signs $770 Million Deal to Acquire Aerie Pharma. I OBN
Swiss eye care company Alcon AG announced on Tuesday that it has entered into a definitive merger agreement with Aerie Pharmaceuticals (AERI.O) in a deal worth around $770 million. This deal complements Alcon’s dedication to the ophthalmic pharmaceutical industry and is…
Selagine and Grifols Team Up for DED Eye Drops
Selagine announced a global collaboration with Grifols to develop and commercialize immunoglobulin eye drops for dry eye disease. Financial terms of the agreement were not disclosed. As per the agreement, Selagine will receive an upfront payment and annual collaboration fee,…
Apotex Recalls Brimonidine Tartrate Ophthalmic Solution
Apotex Corp. has initiated a voluntary recall at the consumer level for 6 lots of brimonidine tartrate ophthalmic solution, 0.15%, distributed nationwide in the United States between April 5, 2022 to February 22, 2023 with the guidance of the US…
Akorn Pharmaceuticals Files for Bankruptcy
Akorn Pharmaceuticals, a maker of generic and branded drugs, has announced that it is ceasing operations business. The company, which provided over 20 ophthalmic products, has filed for chapter 7 bankruptcy, and will close all facilities in the United States. In…
3D-printed Smart Contact Lens with Navigation Function
Dr. Seol Seung-Kwon’s research team on Smart 3D Printing at KERI, in collaboration with Professor Lim-Doo Jeong’s team at Ulsan National Institute of Science and Technology (UNIST), have jointly developed a new core technology for smart contact lenses. The lenses…
M1 Molecule: A Promising Treatment for Optic Nerve Injury
Traumatic injury to the central nervous system (CNS), spinal cord, and optic nerve is the primary cause of disability and the second largest cause of mortality worldwide. CNS injuries frequently result in catastrophic loss of sensory, motor, and visual skills,…